Kok Seong Lim
Independent Cell & Gene Therapy CMC Expert Independent Expert
Kok-Seong Lim, BPharm, PhD, is a pharmaceutical leader with over 20 years of experience in biological research and development, specializing in analytical sciences, quality control, and CMC strategy for advanced therapy platforms. He has held management roles at biotech companies, including Metagenomi, Aura Biosciences and Editas Medicine, as well as at contract manufacturing organizations such as Thermo Fisher Scientific and Brammer Bio.
Seminars
Thursday 26th February 2026
Advancing Viral Vector Manufacturing: NGS-Driven Solutions for Manufacturing Robustness, Product Safety & Regulatory Compliance
10:00 am
- Addressing analytical gaps in viral vector identity, genome integrity, impurity profiles and batch comparability
- Evaluating the role of sequencing in identifying truncated genomes and sequence integrity that impact potency and safety
- Discussing how NGS can be adopted in cGMP environments to meet identity, purity, safety, and comparability requirements
